You have no items in your shopping cart.
Human UBE2V2 [orb2993339]Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.5 KDa. Observed: 18 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μg- Human UBE2R2 [orb2993340]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 29.3 KDa. Observed: 37 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg - Human CASP10 [orb2993345]
Unconjugated
SDS-PAGE: Greater than 70% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 30.1 KDa. Observed: 33 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human UBE2B [orb2993355]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.5 KDa. Observed: 18 KDa, reducing conditions
500 μg, 1 mg, 10 μg, 50 μg - Human PRDX5 [orb2994393]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.9 KDa. Observed: 17 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse KLK7 [orb2994398]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 26.1 KDa. Observed: 28-35 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human UBE2D1 [orb2993293]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 42.9 KDa. Observed: 40 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human UBE2D3 [orb2993301]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.6 KDa. Observed: 15 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human UBA5 [orb2993303]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 47 KDa. Observed: 14&40-60 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human UBE2I [orb2993369]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 44.4 KDa. Observed: 40 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg